Carlos Stalgis

Learn More
Ten patients with interferon-nonresponsive chronic hepatitis C were treated with high-dose interferon-α2b (IFN-α2b; 20 MU/day for two days, then 3 MU/day for 24 weeks, followed by 3 MU three times(More)
Less than 10% of patients with chronic hepatitis C infected with genotype 1 achieve a sustained response with 12 months of interferon therapy. Viral kinetics studies have shown that HCV may replicate(More)
  • 1